Walleye Capital’s Bausch Health BHC Stock Holding History

Walleye Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43K	Sell	290 -1,177,080	-100%	-$6.32M	﹤0.01%	4600
2026 Q1	$6.36M	Buy	1,177,370 +1,163,486	+8,380%	+$6.96M	0.03%	647
2025 Q4	$96.5K	Buy	+13,884	New	+$91.3K	﹤0.01%	3885
2025 Q2	–	Sell	-162,173	Closed	-$1.05M	–	4522
2025 Q1	$1.05M	Buy	162,173 +139,069	+602%	+$999K	﹤0.01%	1932
2024 Q4	$186K	Buy	23,104 +19,337	+513%	+$159K	﹤0.01%	3812
2024 Q3	$30.7K	Buy	3,767 +3,067	+438%	+$20.2K	﹤0.01%	4738
2024 Q2	$4.88K	Sell	700 -14,695	-95%	-$111K	﹤0.01%	5317
2024 Q1	$163K	Buy	+15,395	New	+$135K	﹤0.01%	4098
2020 Q2	–	Sell	-16,363	Closed	-$254K	–	621
2020 Q1	$254K	Buy	+16,363	New	+$395K	0.06%	379
2019 Q4	–	Sell	-80,218	Closed	-$2.09M	–	1796
2019 Q3	$1.75M	Buy	80,218 +58,487	+269%	+$1.34M	0.1%	252
2019 Q2	$548K	Buy	21,731 +21,031	+3,004%	+$499K	0.06%	462
2019 Q1	$17K	Buy	+700	New	+$16.7K	﹤0.01%	1361

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Walleye Capital's BHC Position: Q2 2026 in Review

Walleye Capital reduced its Bausch Health (BHC) stake by 100% in Q2 2026, selling an estimated $6.32M and leaving 290 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4600.

Walleye Capital first reported a position in BHC in Q1 2019 and has held it in 12 quarters since. The position peaked at $6.36M in Q1 2026. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Walleye Capital held 290 shares of Bausch Health worth $1.43K as of Q2 2026.
Walleye Capital sold 1,177,080 Bausch Health shares in Q2 2026, an estimated $6.32M.
Bausch Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4600 holding.
Walleye Capital first reported a position in Bausch Health in Q1 2019 and has held it in 12 quarters since.
Walleye Capital's Bausch Health position peaked at $6.36M in Q1 2026.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.